# Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis

> **NCT00645073** · PHASE4 · COMPLETED · sponsor: **Abbott** · enrollment: 271 (actual)

## Conditions studied

- Acute Bacterial Sinusitis

## Interventions

- **DRUG:** cefdinir (Omnicef)
- **DRUG:** levofloxacin

## Key facts

- **NCT ID:** NCT00645073
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2004-03
- **Final completion:** —
- **Target enrollment:** 271 (ACTUAL)
- **Last updated:** 2008-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00645073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00645073, "Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00645073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*